Sarah Inglis is a clinical trial manager working in the Tayside Clinical Trials Unit. Sarah graduated BSc Physiology from University of Edinburgh in 1990 and PhD in the control of airways secretion from University of Dundee in 1994. Following a postdoc in USA Sarah returned to Dundee and obtained a Wellcome Research Career Development Fellowship. Sarah spent the next 10 years studying small airway secretions in relation to cystic fibrosis and neonatal pulmonary oedema. She moved into clinical trial work in 2009 and since then has managed a numbers of trials, including in respiratory diseases and paediatric mental health. Most recently she has run a complex portfolio of trials for Professor John Dillon, focussed around elimination of Hepatitis C from NHS Tayside.
PhD followed by Wellcome fellowship and 15 years of basic lab work into underlying causes of cystic fibrosis lung disease and neonatal pulmonary oedma.
Currently part of Professor John Dillon’s team running trials aimed at elimination of Hepatitis C from NHS Tayside.
1. Radley A, de Bruin M, Inglis SK, Donnan PT, Dillon JF. Clinical effectiveness of pharmacy-led versus conventionally delivered antiviral treatment for Hepatitis C in patients receiving opioid substitution therapy: A study protocol for a pragmatic cluster randomised trial. 2018;8:e021443. doi:10.1136/bmjopen-2017-021443.
2. McCarthy S, Neubert A, Man KC, Banaschewski T, Buitelaar J, Carucci S, Coghill D, Danckaerts M, Falissard B, Garas P, Häge A, Hollis C, Inglis S, Kovshoff H, Liddle E, Mechler K, Nagy P, Rosenthal E, Schlack R, Sonuga-Barke E, Zuddas A and Wong I.C.K. Effects of long-term methylphenidate use on growth and blood pressure: results of the German Health Interview and Examination Survey for Children and Adolescents (KiGGS) BMC Psychiatry 2018 18:327.
3. Man, KKC; Coghill, D; Chan,EW, Lau, WCY, Hollis, C, Liddle,E; Banaschewski, T; McCarthy,S; Neubert, A; Sayal, K; Ip, P; Schuemie, MJ; Sturkenboom,MCJM; Sonuga-Barke, E; Buitelaar, J; Carucci, S; Zuddas, A; Kovshoff, H; Garas P; Nagy, P; Inglis, SK; Konrad, K; Häge,A; Rosenthal,E; Wong, ICK. Association of Risk of Suicide Attempts with Methylphenidate Treatment. JAMA Psychiatry 2017 doi:10.1001/jamapsychiatry.2017.2183 Published online July 26, 2017.
4. Wong HK, Tiffin PA, Chappell MJ, Nichols TE, Welsh PR, Doyle OM, Lopez-Kolkovska BC, Inglis SK, Coghill D, Shen Y, Tiño P. Personalized Medication Response Prediction for Attention-Deficit Hyperactivity Disorder: Learning in the Model Space vs. Learning in the Data Space. Front Physiol. 2017 Apr 11;8:199. doi: 10.3389/fphys.2017.00199.
5. Inglis S.K., Carucci S. Garas P., Häge A., Banaschewski T., Buitelaar J.K., Dittmann R.W., Falissard B., Hollis C., Kovshoff, H. Liddle E., McCarthy S., Nagy P., Neubert A., Rosenthal E., Sonuga-Barke E., Wong I., Zuddas A., Coghill D.C. and the ADDUCE Consortium. A prospective observational study protocol to investigate long-term adverse effects of methylphenidate in children and adolescents with ADHD: The Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE) study. BMJ Open. 2016 Apr 26;6(4):e010433. doi: 10.1136/bmjopen-2015-010433..
6. Kovshoff H, Banaschewski T, Buitelaar J, Carucci S, Coghill D, Danckaerts M, Dittmann R, Falissard B, Gojkovic D, Hollis C, Inglis S, Konrad K, Liddle E, McCarthy S, Nagy P, Thompson M, Wong I, Zuddas A, Sonuga-Barke E. Reports of perceived adverse events of stimulant medication on cognition, motivation and mood: Qualitative investigation and the generation of items for the Medication and Cognition (MCQ) rating scale. J Child Adolesc Psychopharmacol. 2016 Aug;26(6):537-47
LEGA-C meeting (Local Elimination Programs Leading to Global Action in HCV) Amsterdam, Dec 2018 “A RANDOMIZED TRIAL OF COMMUNITY PHARMACY-LED
TREATMENT FOR HCV PATHWAY COMPARED TO CONVENTIONAL TEST AND REFER PATHWAYS, IN A POPULATION ON OPIOID SUBSTITUTION THERAPY”
INHSU; Cascais, Portugal, Sept 2018 “TOWARDS THE MICROELIMINATION OF HEPATITIS C VIRUS IN TAYSIDE, SCOTLAND, UK”
NRS conference; Perth, October 2018 “PRELIMINARY ANALYSIS OF THE SUPERDOT-C STUDY: A CLUSTER RANDOMISED CONTROLLED TRIAL OF PHARMACY LED VERSUS CONVENTIONAL TREATMENT FOR HCV POSITIVE PATIENTS RECEIVING DAILY OPIOD SUBSTITUTION THERAPY WITHIN NHS SCOTLAND”
ESCAP conference; Geneva, July 2017 “ADDUCE STUDY WP3”